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Abstract
Background: Atypical prostatic hyperplasia (APH) is a pseudoneoplastic lesion that can mimic prostate
adenocarcinoma because of its cytologic and architectural features. Suspension of date palm pollen (DPP) is an
herbal mixture that is widely used in folk medicine for male infertility. The aim of the present study was to
evaluate the effect of DPP suspension and extract on APH-induced rats.
Methods: APH was induced in adult castrated Wistar rats by both s.c. injection of testosterone (0.5 mg/rat/day)
and smearing citral on shaved skin once every 3 days for 30 days. Saw palmetto (100mg/kg), DPP suspension (250,
500 and 1000 mg/kg), and lyophilized DPP extract (150,300 and 600 mg/kg) were given orally daily for 30 days. All
medications were started 7 days after castration and along with testosterone and citral.
Results: The histopathological feature in APH-induced prostate rats showed evidence of hyperplasia and
inflammation. Immunohistochemical examination revealed that the expressions of IL-6, IL-8, TNF-a, IGF-1 and
clusterin were increased, while the expression of TGF-b1 was decreased that correlates with presence of
inflammation. Moreover, histopathological examination revealed increased cellular proliferation and reduced
apoptosis in ventral prostate. Both saw palmetto and DPP treatment has ameliorated these histopathological and
immunohistochemical changes in APH-induced rats. These improvements were not associated with reduction in
the prostatic weight that may be attributed to the persistence of edema.
Conclusion: DPP may have a potential protective effect in APH-induced Wistar rats through modulation of
cytokine expression and/or upregulation of their autocrine/paracrine receptors.
Keywords: atypical prostatic hyperplasia, date palm pollen, anti-inflammatory, antiproliferative, cytokines, immuno-
histochemistry, castration, citral
Introduction
Benign prostatic hyperplasia (BPH) is a hormone- and
age-related disease, characterized by histological changes
and variable increases in prostatic size [1]. Atypical pro-
static hyperplasia (APH) or adenosis is a pseudoneoplas-
tic lesion that can mimic prostate adenocarcinoma
because of its cytologic and architectural features. APH is
usually an incidental finding in transurethral resections
or simple prostatectomies performed in the clinical set-
ting of BPH [2]. In these prostate diseases, there is an
imbalance between prostate cell growth and apoptosis.
This imbalance is complex and influenced by factors that
stimulate proliferation and minimize cell apoptosis such
as growth factors, cytokines and steroid hormones [3].
T h er o l eo fi n f l a m m a t i o ni np r o s t a t ed i s e a s e si ss u g -
gested by the presence of inflammatory cells within the
prostate in BPH patients [4]. The more the inflamma-
tion, the larger the prostate will be [5]. Inflammation is
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kines) and cellular (leukocytes, monocytes and macro-
phages) components [3]. Inflammation is usually a self-
limited event, with initial pro-inflammatory cytokines,
growth factor release and angiogenesis followed by anti-
inflammatory cytokine-mediated resolution [6]. Chronic
inflammation continuously produces inducible cyclooxy-
genase (COX-2) that increases the production of prosta-
glandin-E2 (PGE2) and reduces the E-c adherin protein
[7]. Chronic inflammation also produces free radicals as
various reactive oxygen species (ROS) [8].
Suspension of Phoenix dactylifera date palm pollen
(DPP) is an herbal mixture that is widely used as a folk
remedy for curing male infertility in traditional medicine
[9]. A thousand tonnes of DPP are produced every year
by millions of palm trees grown in the Arabian region.
DPP differed from bee pollen in that it is of a known
source and its homogeneity, purity and is easily to be
standardized. DPP was reported to have gonadal stimu-
lating potency [10], as well as fertility promotion in
women in ancient Egypt [11]. It was reported that date
pollen grain extracts contain estrogenic materials,
estrone, as gonad-stimulating compounds that improve
male infertility and exhibit gonadotrophin activity in the
rat [11,12]. Cernilton is another pollen extract derived
from several different plants in southern Sweden and
has been known to be effective in the treatment of
chronic abacterial prostatitis and prostatodynia [13,14].
The aim of this study was to investigate the protective
effect of DPP suspension and its alcoholic extract on the
histpathological changes related to inflammation, prolif-
eration and/or apoptosis in APH using citral and testos-
terone-induced APH model in castrated rats.
Methods
Chemicals and reagents
Antibodies against clusterin, phospho-Smad2, and b-actin
were obtained from Santa Cruz Biotechnology (Santa
Cruz, CA; anti-clusterin for Western blot analysis);
Upstate Biotechnology [Lake Placid, NY; anti-clusterin for
immunohistochemistry (IHC)]; and Cell Signaling Tech-
nology Inc. (Danvers, MA). Antibody against TGF-b1
ligands were purchased from Dakocytomation (Carpin-
teria, CA). Citral was obtained from Fluka Chemie AG,
Buchs, Switzerland. Testosterone was obtained from
Sigma-Aldrich and Dakocytomation (Carpinteria, CA).
Collection and extraction of date pollen sample
Date palm pollen sample was collected from El-Kata-
wiah, El-Sharkia, Egypt. It was collected in March 2010
and kept in 20°C till extraction. 1250 g DPP powder was
extracted with 80% ethanol (3 × 5 liters) by using Ultra-
turrax T25 homogeniser (Janke and Kunkel, IKA Labor-
technik, Stauten, Germany) at a temperature not
exceeding 25°C. The extract was evaporated under
reduced pressure, lyophilized to give 240 g of yellowish
semisolid residue and protected from light at 4°C until
use.
Experimental animals
Adolescent male Wistar rats, aged 50-60 days, were
obtained from the animal facility of King Fahd Research
Center, King Abdulaziz University, Jeddah, Saudi Arabia.
They were used in the study according to the guidelines
of the Biochemical and Research Ethics Committee at
King Abdulaziz University, in accordance with the NIH
guidelines. Animals were housed in a well-ventilated,
temperature-controlled room at 22 ± 3°C with a 12 h
light-dark cycle. They were provided with standard rat
chow pellets and tap water. All experimental procedures
were performed between 8-10 a.m. and care was taken to
avoid stressful conditions.
Orchidectomy was performed aseptically, under ethyl
ether anesthesia, by a midscrotal incision. Following
ligation of the spermatic cord and vessels, testes and
epididymides were removed. The remaining stump was
pushed back through the inguinal canal into the abdom-
inal cavity, and the scrotal sac was closed by sutures
[15]. After castration, the rats were maintained under
standard laboratory conditions for 7 days in order to
allow a definite involution of the prostatic gland [16].
APH was induced as previously described by Engelstein
et al. [17] in castrated rats using citral and testosterone.
Rats were subcutaneously injected with testosterone pro-
pionate in corn oil (0.5 mg/0.1 ml/rat) each day for 30
days. Citral, 1 M diluted in 70% ethanol, was smeared on
a different shaved area of skin, each time, on the back at
a final dose of 185 mg/kg every 4
th day for 30 days. Con-
trol groups were smeared with the solvent (ethanol)
alone at the shaved skin. Considering the pungent lime
fragrance of citral, the control groups were kept in a
separate location from the citral-treated animals to avoid
possible false results as citral have some influence via the
olfactory tract [17].
Animal treatment
Seven days after castration, the animals were randomly
divided into nine groups (n = 7). Group I served as
shamed operation received corn oil (0.1 ml/rat) and 1%
CMC-Na (0.3 ml/100 g body wt) daily during the period
of the experiment. Groups from II-IX were castrated
and had APH. Group II served as negative control and
received CMC-Na 1% as previously mentioned. Group
III served as positive control and received saw palmetto
(100 mg/kg). Groups from IV-VI were treated with DPP
suspension (DPPS) at doses of 250, 500 or 1000 mg/kg/
day respectively by oral gavage. Groups from VII-IX
were treated with 150, 300, or 600 mg/kg/day of DPP
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extract were suspended in 1% CMC-Na and were given
to rats once daily by oral gavage along with testosterone
injection and citral smearing for 30 days as described
before by Scolnik et al. [18]. After scarifaction, ventral
prostate of each rat in each group were removed from
the body, 24 hr after the last administration, and
weighed. Half of the tissues were frozen in liquid nitro-
gen and stored at -75°C until use. The remaining tissues
were fixed immediately in 0.1 M phosphate-buffered
10% formalin (pH 7.4) for 48 h and then embedded in
paraffin and were used for histological studies. Serial 4-
μm-thick sections from each tissue specimen were pre-
pared and mounted on poly-L-lysinecoated glass slides.
These were used for detection of IL-6 and TGF-b1
receptors by immunohistochemistry.
Histopathology and Histoscore
A part of the ventral lobes were separated and fixed
overnight in Stieve’s solution. Thereafter, the tissue was
thoroughly rinsed with water, and immersed overnight
in ethanol 70%. Then, it was dehydrated, embedded in
paraffin, and 5 mm thick sections were cut and stained
by Harris’ hematoxylin eosin, according to standard pro-
cedures [19].
A score-chart protocol (histoscore) developed by Scolnik
et al. [18] was used to obtain an objective quantitative
assessment (Table 1). The examination, description, and
scoring of the slides were performed in a blinded manner.
The scoring system presented in arbitrary units to make a
better evaluation. In a second step, the cumulative score in
each group were correlated to the final histological diagno-
sis in order to establish a range score for normal and
hyperplasia. Additional histological inflammatory score
d e s c r i b e db yD eN u n z i oe ta l .[ 2 0 ]w a su s e dt oe v a l u a t e
the inflammation. Score 0: no inflammation, Score 1: scat-
tered inflammatory cell infiltrate without nodules, score 2:
no confluent lymphoid, score 3: Large inflammatory areas
with confluence.
Immunohistochemistry and Immunhistoscoring
Hematoxylin and eosin staining was performed to
observe histopathology. For analysis of IL-6 and TGF-b1
expression, sections from the paraffin embedded tissue
blocks were mounted on charged glass slides and baked
at 60°C for 1 hr in the oven, then mounted in Ventana
staining machine. Dewaxed by EZ Prep (Xylene substi-
tute) and rehydrated. The tissue sections were heated in
Ventana buffer CC1 (pH 6) to facilitate antigen retrieval,
treated with H2O2 to eliminate endogenous peroxidase.
This was followed by incubation for 60 min at room tem-
perature with primary antibodies IL-6 and TGF-b1. The
dilutions used were; IL-6 (dilution 1:50) and TGF-b1
(dilution of 1:25). Subsequently, the sections were
incubated with biotinylated secondary antibody using avi-
din-biotin complex method. The immunoreaction was
visualized using diaminobenzidine. All sections were
lightly counterstained with hematoxylin as a back
ground. The positive controls used for IL-6 and TGF-
bR1 were from the colon. The negative controls com-
prised serial sections that were stained using equivalent
concentrations of nonimmune mouse IgG in place of the
primary antibodies. The level of staining was evaluated
independently by three observers blinded to experimental
conditions.
Expression of TGF-b1 and IL-6 was evaluated accord-
ing to a semiquantitative scale: -0, no detectable staining
at all; 1, less than 10% of the cells stained positive; 2, 10
-50% positive cells; and 3, more than 50% of cells posi-
tive [21]. Staining intensity was scored as 0 (no detect-
able stain), 1 (weak staining detected at intermediate to
high power), 2 (moderate detected at low to intermedi-
ate power) to 3 (strong detected at low power) [22].
Reverse transcriptase-polymerase chain reaction (RT-PCR)
Total RNA was extracted from the snap-frozen tissue
samples using total RNA isolation kit (Macherey-Nagel)
according to the manufacturer’s instructions. RT was per-
formed in a 10 μl reaction mixture. The RT reaction con-
tained 1 μg RNA, 10 mM Tris-HCl (pH 8.3), 50 mM KCl,
1.5 mM MgCl2, 2.5 mM dithiothreitol, 500 μmol/liter
each of dATP, dCTP, dGTP, and dTTP, 40 U RNasin, 25
μg/ml oligo d(T)12-18, and 100UMoloney murine leuke-
mia virus reverse transcriptase (Bioline, London, UK). The
reaction mixture was incubated at 42°C for 60 min and
then heated to 80°C for 5 min. The resultant cDNA was
used for PCR. For quantitative real-time RT-PCR, we pre-
pared appropriate dilutions of each single-strand cDNA
followed by normalizing of the cDNA content using b-
actin as a quantitative control. Quantitative PCR amplifi-
cation was performed with a 25-μl final volume consisting
of 1 μl RT reaction mixture, 3 mM MgCl2, 10 pmol of
each sense and antisense primer, and 12.5 μl (Roche Diag-
nostics) (Table 2). PCR conditions were as follows: initial
denaturation at 95°C for 10 min and 35 cycles of denatura-
tion at 94°C for 1 min, annealing at 55°C for 1 min, and
elongation at 72°C for 2 sec with a final elongation at 72°C
for 10 min. samples were migrated in 1% agarose gel using
electrophoresis, UV visualized, and images were analyzed
using totallab120 (Nonlinear Dynamic Ltd). Clusterin,
TGF-b1, IGF-1, IL-6, IL-8, and TNF-a expression in the
test samples were normalized to the corresponding b-actin
level and were reported as the relative band intensity to
the b-actin gene expression.
Statistical analysis
Data were expressed as mean ± SE and were analyzed
by analysis of variance (ANOVA) followed by Tukey-
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and their significance were calculated by Chi-square test
with Yate’s corrections. Differences were considered sig-
nificant with a P value less than 0.05. Statistical analyses
were performed using the SPSS for Windows (v. 10.0).
Results
Changes in relative prostate weight
Prostatic weights were increased significantly in APH-
induced rats. There were no significant changes in rela-
tive prostate weight after treatment with either, saw pal-
metto, DPPS or DPPE (Table 3).
Changes in gene expression of IL-6, IL-8 and TNF-a
Induction of APH in rats significantly increased the gene
expression of proinflammatory cytokines; IL-6, IL-8 and
TNF-a. Saw palmetto treatment exerted a significant
reduction in their levels compared to APH-induced rat
values. DPPE induced a similar effect to that of saw pal-
metto in a dose dependent manner. On the other hand,
despite DPPS in a dose of 250 mg/kg increased the gene
expression IL-6, IL-8 and TNF-a, it induced a dose-
dependent reduction of these genes at doses of 500 and
1000 mg/kg (Figure 1).
Changes in gene expression of TGF-b1, IGF-1 and
clusterin
Induction of prostatic hyperplasia in our model is accom-
panied with significant increase of the clusterin and IGF-
1 expression in ventral lobe of rat prostate, while the
TGF-b1 expression was significantly decreased. Saw pal-
metto treated rats with APH showed significant increase
in clustrin and TGF-b1 expression with a decrease in
IGF-1 expression. All the treatment groups showed
Table 1 Cumulative chart score of histological findings (Arbitrary Units) in rat ventral prostate [19]
Strain Experimental group Animal no.
subtotal
Low-Power Magnification
Luminal shape regular (1); villous (3); papillary (4); cribriform (5) ————
Acinar shape tubular (1); branched (3); irregular (5) ————
Interacinar shape large or moderate (1); back-to-back glands (5) ————
Stroma fine (1); abundant (3); fibrosis/severe smooth muscle hyperplasia (5) ————
High-Power Magnification
Epithelial shape: flattened (1); cuboidal (1); cylindrical (3); hexagonal (5) ————
Number of layers: mono- (1); oligo, 2-4 (3); pluri, > 5 (5)
If > 1, then add: focal (3); diffuse (5)
————
Alignment: Polar (1); apolar (3)
If there is piling up of epithelial cells add (3)
If there is budding out of epithelial cells into stroma add (5)
If periacinar clusters of epithelial cells are found add (3)
If isolated clusters of epithelial cells are found outside acini add (5)
————
Lesion distribution Unilobar: isolated (2); multiple (6)
Bilobar: isolated (4); multiple (8)
————
Nuclear shape: Round, regular (1); irregular (5)
Small (2), large (2), small and large in the same acinus (4)
————
Mitoses per field: absent (0); isolated, 1-2 (2);
abundant, 3-5 (5); excessive, > 5 (10)
————
Basement membrane: Intact (1); interrupted (5)
Thin (1); thick (5)
————
Total score (arbitrary units) ————
Other Findings: edema; congestion; hemorrhages; pyknotic nuclei-epithelial/stromal; mononuclear exudate-stromal/intraluminal
Table 2 Primer for quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) analysis
Gene Forward primer Reverse primer
b-actin 5’-GTCACCCACACTGTGCCCATCT-3’ 5’-ACAGAGTACTTGCGCTCAGGAG-3’
IL-6 5’-GAACTCCTTCTCCACAAGCG-3’ 5’-TTTTCTGCCAGTGCCTCTTT-3’
IL-8 5’-CTGCGCCAACACAGAAATTA-3’ 5’-ATTGCATCTGGCAACCCTAC-3’
TNFa 5’-CAGAGGGAAGAGTTCCCCAG-3’ 5’-CCTTGGTCTGGTAGGAGACG-3’
TGF-b 5’-GTTCTTCAATACGTCAGACATTCG-3’ 5’-CATTATCTTTGCTGTCACAAGAGC-3’
IGF-1 5’-CACAGGCTATGGCTCCAGCAT-3’ 5’-TCTCCAGCCTCCTCAGATCACA-3’
Clusterin 5’-CTGACCCAGCAGTACAACGA-3’ 5’-TGACACGAGAGGGGACTTCT-3’
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accompanied with decreasing of IGF-1 expression in a
dose dependent fashion (Figure 2).
Histological changes
Ventral prostates from the control normal group
showed normal histological pattern with regular acini
and average histoscore of 23.3 ± 1.09 units (Table 4).
Ventral prostates from the APH-induced rats showed an
increased irregular acinar growth and distribution. The
acini were placed back to back with vilous projections.
The lining epithelium was tall columnar with abundant
eosinophilic cytoplasm. Nuclei were round, regular and
basally placed in most acini. Epithelial pilling with focal
loss of polarity and budding into surrounding stroma
was seen in some prostatic sections. The basement
membrane was thin and continuous. Isolated mitotic fig-
ures were seen in the range of 1-2/section examined.
The interstitial stroma was scant and showed congested
blood vessels with chronic inflammatory cells mainly
lymphocytes and perivascular. These findings were asso-
ciated with significant increase in the histoscore (Table
4 and Figure 3).
These pathological changes and histoscore were ame-
liorated in animals in the saw palmetto group (Table 4
and Figure 4). However, irregular and back to back
acini, with focal pilling of epithelium, were persistent in
isolated and multiple foci within the prostatic sections.
These acini were lined by tall columnar epithelium and
showed round, regular basally placed nuclei. No loss of
polarity or budding into surrounding stroma was seen.
Isolated mitotic figures in the range of 1-2/section were
seen. The interstitial stroma was scant and showed vas-
cular congestion. Rare chronic inflammatory cells were
seen.
Similarly, DPPS (250, 500, 1000 mg/kg) and DPPE
(150, 300, 600 mg/kg) ameliorated both the pathological
features and histoscore of APH (Table 4 and Figure 4).
However, persistent hyperplastic changes were seen with
an uneven distribution. Most of the affected acini were
dilated with intraluminal secretions. Few acini showed
focal loss of lining epithelium although the basement
membrane was still intact. Mitotic figures were absent
in most cases and surrounding stroma showed edema.
Occasional mixed acute and chronic inflammatory cells
were seen along with few mast cells. Regarding the
inflammatory score, treatment with saw palmetto, DPPS
and DPPE showed significant inhibition of inflammation
nearly in a non-dose dependent manner (Table 4).
Immunohistochemistry
Normal control rats showed no expression of all the
three immunohistochemical markers. In the prostatic
sections from APH-induced rats, TGF-b1e x p r e s s i o n
score was 3 and showed strong intensity in the secretory
epithelial cells of acini with focal strong expression in
basal cells as well. IL-6 expression score was 1 and
showed weak intensity in the secretory epithelial cells
only. No expression was observed in secretory, basal or
stromal cells (Figure 5).
In saw palmetto treated APH-induced rats, TGF-b1
expression score was 3 and showed strong intensity in
the secretory epithelial cells of acini with focal strong
expression in basal cells as well. IL-6 was variable
between score 2-3 with a staining intensity between
moderate to strong. No expression was observed in
secretory, basal or stromal cells.
In DPPS (250 mg/kg) treated rats, TGF-bR1 expres-
sion score was 2 and showed moderate intensity in the
secretory epithelial cells of acini with focal moderate
expression in basal and stromal cells as well. IL-6
expression score was 2 with a strong staining intensity.
No expression was observed in secretory, basal or stro-
mal cells (Figures 6 and 7).
Table 3 Body weight (BW), absolute prostate weight (APW), and relative prostate weight (RPW) of rats treated with
date palm pollen suspension (DPPS) and the alcoholic extract (DPPE)
Treatment group BW (gm) ABW (gm) RBW (gm)
start end
Normal rats 199.14 ± 5.16 229 ± 8.810 0.106 ± 0.011 0.452 ± 0.051
Rats with APH (negative control) 187.6 ± 8.656 241.4 ± 12.55 0.656 ± 0.056 2.721* ± 0.197
Saw Palmetto (100 mg/kg) 192.8 ± 4.591 258.3 ± 10.22 0.742 ± 0.036 2.919* ± 0.217
DPPS (250 mg/kg) 190 ± 5.024 243.6 ± 11.89 0.752 ± 0.025 3.15* ± 0.215
DPPS (500 mg/kg) 178.3 ± 4.207 221.8 ± 7.127 0.745 ± 0.051 3.38* ± 0.274
DPPS (1000 mg/kg) 193.7 ± 8.929 275 ± 11.547 0.75 ± 0.084 2.79* ± 0.342
DPPE (150 mg/kg) 215 ± 7.693 244.5 ± 8.675 0.719 ± 0.044 2.92* ± 0.193
DPPE (300 mg/kg) 189.7 ± 7.136 232.9 ± 9.425 0.696 ± 0.056 3.039* ± 0.343
DPPE (600 mg/kg) 184 ± 5.219 244.8 ± 9.502 0.752 ± 0.036 3.10* ± 0.197
(n = 7 rats in each group).
*Significantly different from normal rats at p < 0.05.
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TGF-b1 expression was score 3 and showed strong
intensity in the secretory, basal epithelial cells of acini
and stromal cells. IL-6 expression score was 3 with a
strong staining intensity in secretory and stromal cells.
The basal cells also showed focal strong expression of
IL-6 with score 3. No expression was observed in secre-
tory, basal or stromal cells. Although the immunoscore
enhanced with increase in dose of DPPS from 250 mg/
kg to 500 mg/kg, but no statistically significant dose
related correlation was observed between a dose of 500
mg/kg and 1000 mg/kg.
In prostatic sections examined from the DPPE (150
mg/kg) treated rats, TGF-b1 expression was variable
between score 2-3 and showed moderate to strong
intensity in the secretory and basal epithelial cells of
acini and stromal cells. IL-6 expression was score 3 with
a strong staining intensity in secretory and stromal cells.
The basal cells showed focal strong expression with
score 3. No expression was observed in secretory, basal
or stromal cells
In DPPE (300 mg/kg and 600 mg/kg) treated rats,
TGF-b1 expression score was 3 and showed strong
intensity in the secretory and basal epithelial cells of
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Figure 1 The expression of IL-6, IL-8 and TNF-a target genes in ventral prostate of Wistar rats after treatment with DPPS and DPPE.
All values are expressed as mean ± S.E. of the relative band intensity (R.B.I.) using b-actin as a reference. *Significantly different from normal
control rats at P < 0.05. # Significantly different from APH control rats received CMC at P < 0.05.
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a moderate to strong staining intensity in secretory and
stromal cells. The basal cells showed focal strong
expression with score 3. No expression was observed in
secretory, basal or stromal cells. Although the immuno-
score enhanced with increase in dose of DPPE from 150
mg/kg to 300 mg/kg, but no statistically significant dose
related correlation was observed between a dose of 300
mg/kg and 600 mg/kg (Figures 6 and 7).
Discussion
The fact that APH arises always in prostates with con-
comitant BPH and exhibits several cancer like features,
places APH as an intermediate lesion between BPH and
the subset of well-differentiated prostatic cancers
according to Bostwick et al. [23]. The pathogenesis of
prostatic hyperplasia still remains largely unresolved, but
a number of partially overlapping and complementary
theories have been proposed. In the current study,
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Figure 2 The expression of TGF-b1, IGF-1 and Clusterin target genes in ventral prostate of Wistar rats after treatment with DPPS and
DPPE. All values are expressed as mean ± S.E. of the relative band intensity (R.B.I.) using b-actin as a reference. *Significantly different from
normal rats at P < 0.05. # Significantly different from APH control rats received CMC at P < 0.05.
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consequence of progressive acinar hyperplasia that con-
firmed the influence of androgen on prostate growth.
These findings are in agreement with that of Abramovici
et al. [24]. The development of hyperplasia was asso-
ciated with enhanced proliferation and suppressed apop-
tosis of prostatic cells. The APH-induced rats showed
an increase in both absolute and relative weights of ven-
tral prostate lobe. This effect was accompanied by histo-
pathological changes confirming the APH which was in
agreement with that of Abramovici et al. [24] and Engel-
stein et al. [17]. It was suggested that APH induced in
adult rats by citral may be attributed to its estrogenic-
like effect through its binding nonspecifically to estrogen
Table 4 Histoscore and inflammatory scores in normal rats, atypical prostatic hyperplasia (APH)-induced rats and APH-
induced treated treated with date palm pollen suspension (DPPS) and the alcoholic extract (DPPE) (n = 7 rats in each
group)
Treatment group Histoscore Inflamm-atory
score
Number of cases of inflammati-
on/tested rats
Percentage
inflammation
Percentage inhibition of
inflammation
Normal rats 23.30 ± 1.09 0 0 - -
Rats with APH
(negative control)
40.14* ± 1.97 1 7 100* 0
Saw Palmetto (100
mg/kg)
35.28* ± 2.37 1 1 14.28* 85.72
#
DPPS (250 mg/kg) 36.00* ± 2.21 1 1 14.28* 85.72
#
DPPS (500 mg/kg) 34.20* ± 2.75 1 1 14.28* 85.72
#
DPPS (1000 mg/kg) 34.70* ± 1.58 1 0 0 100
#
DPPE (150 mg/kg) 36.40* ± 2.51 1 1 14.28* 85.72
#
DPPE (300 mg/kg) 34.20* ± 1.96 1 1 14.28* 85.72
#
DPPE (600 mg/kg) 34.70* ± 1.97 1 1 14.28* 85.72
#
*Significantly different from normal control rats at p < 0.05
# Significantly different from APH control rats received CMC at p < 0.05
Score 0: No inflammation
Score 1: Scattered inflammatory cells without nodules
Score 2: No confluent lymphoid aggregates
Score 3: Large areas of confluence
Figure 3 Prostate of normal rats with round regular acini with an intact basement membranes, the acinar lumina contain eiosinophilic
and homogeneous secretions (A), citral and testosterone treated castrated rats with atypical prostatic hyperplasia (APH) showed an
irregular acinar growth and distribution, the acini were increased in number, lined by tall columnar epithelium, crowded, irregular in
outline and placed back to back with vilous projections (B), the intersititial stroma was scant and showed congested blood vessels
with chronic inflammatory cells mainly perivascular lymphocytes (C) hyperplastic acini showing mitosis (D).
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Page 8 of 13receptors [25] located on prostate epithelial cells of both
human [26] and rat [27]. Ho, et al. [27] also found that
induction of type 2 estrogen-binding site in rat ventral
prostate could be responsible for the proliferative
response.
The hyperplastic changes induced in ventral prostate of
rats in the current model were accompanied with an
increased gene expression of IGF-1, IL-6, IL-8, TNF-a and
decreased TGF-b1. TGF-b1 is the only known growth fac-
tor that can suppress tissue proliferation and induce cell
Figure 4 Normal rats ventral prostate (A), APH in the ventral rat prostate (B), Saw palmetto treated rats prostate showed a persistent
hyperplastic acini that were lined by tall columnar epithelium with villous projections and rare chronic inflammatory cells in the
stroma (C), DPP suspension (DPPS) showing decreased number of hyperplastic acini in the overall distribution of the lesion (D),
hyperplastic acini showing focal loss of lining epithelium (E) few mast cells in the surrounding stroma along with edema (F) and
occasional mixed acute and chronic inflammatory cells were seen (G). The prostate of the DPPE treated rats, showed a decrease in the
number of acini in the overall distribution of the lesion (H) and dilated acini with intraluminal secretions, mitotic figures and chronic
inflammatory cells were absent in most cases and surrounding stroma was edematous (I).
Figure 5 Immunohistochemical identification and quantification of TGF-bI and IL-6 of: Normal rat prostate TGF-bI score 0 (A), Normal
rat prostate IL-6 score 0 (B) APH control rat prostate TGF-bI score 3 (C) and APH control rat prostate IL-6 score 1 (D).
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Page 9 of 13apoptosis [28]. Circulating testosterone acts locally in the
prostate via the production of growth factors such as IGF
and TGF families that act in an autocrine or paracrine
manner to influence prostate cell growth, survival, or
apoptosis [29]. There are essentially two major classes of
growth factors that are complimentary due to their effects
on cell growth, namely growth stimulatory or mitogenic
factors such as IGFs and growth inhibitory factors, includ-
ing TGF-b1. The prostate enlargement and the increased
n e tw e i g h to ft h ev e n t r a ll o b em a yb ep a r t l yd u et o ,t h e
increased IGF-1 and decreased TGF-b1expression. This
modulation in expression of these cytokines may play a
Figure 6 Immunohistochemical identification and quantification of TGF-bRI, in APH control rat prostate score 2-3 (A), APH rat prostate
treated with Saw Palmetto 100 mg kg score 3 (B), APH rat prostate treated with DPPS (1000 mg kg) score 3 (C) and APH rat prostate
treated with DPPE (600 mg kg) score 3 (D).
Figure 7 Immunohistochemical identification and quantification of IL-6 in; APH control rat prostate score 1 (A), APH rat prostate
treated with Saw Palmetto (100 mg/kg) score 2-3 (B), APH rat prostate treated with DPPS (1000 mg/kg) score 3 (C) and APH rat
prostate treated with DPPE (600 mg/kg) score 3 (D).
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Page 10 of 13crucial role in prostate cell proliferation and apoptosis.
These finding are in agreement with that of Wu et al. [30].
IGF-1, a mitogen, interacts with IGF-1 receptor stimulat-
ing cell proliferation [31] and inducing proliferative pro-
static diseases [32].
Inflammation may play a role in prostatic hyperplasia
[33]. About 40% of patients with BPH and APH exhibit
chronic inflammatory features including infiltration by
activated T cells, mast cells and macrophages [34].
Results of the present study showed that the enlarge-
ment of the ventral prostate of rats may be in part due
to inflammation and over-expression of the pro-inflam-
matory cytokines including IL-6, IL-8 and TNF-a.I t
was reported that the infiltrated cells are capable of
secreting growth factors and proinflammatory cytokines
such as IL-6, IL-8, TGF-b1a n dI F N - a [33]. IL-6 is also
secreted by both normal and prostatic epithelial cells
and acts as a growth factor for normal prostatic epithe-
lial cells [35]. IL-8 has chemotactic properties, attracting
neutrophils and mononuclear cells into the sites of
inflammation. It is a primary inflammatory cytokine,
secreted by monocytes, mitogen-stimulated T lympho-
cytes, and many other prostatic cells [36]. IL-8 mRNA
expression was upregulated as much as 5-fold in periph-
eral blood lymphocytes of patients with prostatic carci-
noma and in prostate tissues with hyperplasia and can
act as a paracrine inducer of some potent growth factors
for prostatic stromal cells [37]. TNF-a, a pro-inflamma-
tory cytokine, may induce inflammation by induction of
COX-2, superoxide and hydrogen peroxide in human
and rat mesangial cells [38]. TGF-b, an inflammatory
cytokine, has been shown to regulate stromal prolifera-
tion and differentiation in BPH, and it is a key factor for
androgen control of prostatic growth. Recently, Desca-
zeaud et al [39] investigated the TGF-b receptor II pro-
tein (TGFBRII) expression in 231 BPH patients using
large-scale tissue microarrays analysis. They observed a
significant association between TGFBRII stromal stain-
ing and prostatic volume.
Results of the present study showed that administra-
tion of DPPS and DPPE has ameliorated the histopatho-
logical changes and pro-inflammatory cytokine
expression in APH-induced rats in a dose dependent
manner as well as the inflammatory score in a non-dose
dependent manner. These findings are in agreement
with that of Ito et al. [40]. They reported that cernilton,
the water soluble fraction of pollens extract of different
plants, produced histological evidence of epithelial cell
atrophy and significant reduction in the size of ventral
and dorsal lobes of prostate in mature Wistar rats.
These effects may be due to the anti-inflammatory activ-
ity of the DPP. In the context of chronic inflammation
and expression of proinflammatory cytokines, IL-6 is
one of the major physiologic mediators of acute phase
reaction that influence immune responses and inflam-
matory reactions [36].
Pollen extract contains five different phytosterols and
a biological active peptide that can influence the intra-
cellular metabolism in biological systems [13]. Pollen
extract showed a decrease in the leucocyte number in
the prostatic expressate in 59% of all cases [13]. The
water-soluble fraction attenuated the inflammatory
response in experimental animals [41]. The in vitro
experiments suggested that GBX (an acetone-soluble
cernitin pollen extract) could be either a smooth muscle
relaxant or a potent cyclo-oxygenase and lipoxygenase
inhibitor [14]. The selectivity of pollen extract for the
prostate was also supported by the work carried out by
Ito et al. [40]. The homogenous effect of pollen-extract
on the bladder outflow obstruction, showed higher
values of urine volume voided and reduced flow time in
both prostatitis and BPH [13]. The anti-inflammatory
and decongestive effects of pollen-extract, give the evi-
dence for the therapeutic benefit in patients with non-
bacterial prostatitis or prostodynia [13,42]. The signifi-
cant decrease in the A-P diameter of the prostate in
patients treated with cernilton suggests that the prostate
size was reduced. Nakase et al. [43] reported that T-60
(a water-soluble cernitin pollen extract) and GBX inhib-
ited the contraction of muscle induced by noradrenaline,
with evidence for competitive antagonism of noradrena-
lin at the site of adrenergic receptors. The subjective
improvement in symptoms of nocturia and bladder
emptying could be due to the effect of pollen extract on
the rich adrenergic innervation of the bladder neck and
prostate [44]. Similar findings were recorded in the pre-
sent study in APH-induced rats treated with saw pal-
metto. Saw plametto was reported to inhibit growth
factors-induced cell proliferation [45]. It has been
reported that the liposterolic extract of Saw palmetto
has antiandrogenic effects, [46] and inhibits the type 1
and type 2 isoenzymes of 5-alpha-reductase [47].
The reduction in the number of acini and the absence
of mitotic figures in the surrounding stroma during
treatment with both DPPS and DPPE may be due to
increased tissue apoptosis and decreased proliferation.
Results of the present study showed that DPP increased
the expression of TGF-bI and clusterin while decreased
the expression of IGF-1 in rat ventral lobe prostate.
Overexpression of TGF-b1 and clusterin showed the
increased rate of apoptosis of acini on the ventral
prostate.
Conclusion
The findings of the present study clearly suggest that
suspension or extract of DPP has ameliorating effect on
the prostatic hypertrophy and inflammation. DDP treat-
ment reduced the number of prostatic acini in APH rat
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tory cytokines. Prostatic tissues proliferation was
decreased and apoptosis was increased during the treat-
ment with DPP suspension and extract. The watery
edema found during DDP treatment was responsible for
the increased volume and hence the weight of the ven-
tral lobe. This may explain the non-significant change of
ventral prostate weight after treatment despite of the
anti-inflammatory, antiproliferative and apoptotic effects.
Further studies may be required for longer time treat-
ment to study the effects of DPP on the absolute and
relative weight of ventral lobe as well as the total net
weight of the prostate in this model of APH in rats.
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